This condition could explain why mice with severe hepatic insulin resistance, due to the absence of hepatic insulin receptor substrates (IRSs) IRS1 and IRS2, exhibit reduced obesity and lower circulating levels of FGF21 [6]. This evidence concerns the gene FGF21 and Insulin resistance.